Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Darman Yab Darou is a prominent Iranian pharmaceutical company established in 1998, specializing in the importation, distribution, and local manufacturing of high-quality medicinal products. The company serves as a strategic partner and exclusive representative for several leading global pharmaceutical firms, including Merck KGaA (Merck Serono) and Servier, facilitating the availability of advanced treatments in Iran. Its portfolio covers critical therapeutic areas such as neurology, endocrinology, cardiology, and reproductive health, with a focus on specialized biologics and essential small molecule drugs. In addition to its extensive distribution network, Darman Yab Darou has invested in domestic manufacturing capabilities to enhance the self-sufficiency of the Iranian healthcare sector. The company is recognized as one of the largest importers of specialized medicine in the country, playing a vital role in patient access to life-saving therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Darman Yab Darou.